Samuel G. Liss
Known title: DirectorCIK: 0001242238
Associated companies
Transaction History
| VRSK | ▲ Buy | Grant | 156 | $0 | 9/30/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 167 | $0 | 6/30/2026 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,671 | $378K | 6/5/2026 | View on chart |
| VRSK | ▼ Sell | Open Market | 4,671 | $851K | 6/5/2026 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 6,765 | $547K | 6/2/2026 | View on chart |
| VRSK | ▼ Sell | Open Market | 6,765 | $1.2M | 6/2/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 1,347 | $0 | 5/19/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 158 | $0 | 3/31/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 134 | $0 | 12/31/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 119 | $0 | 9/30/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 96 | $0 | 6/30/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,716 | $344K | 6/13/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 1,153 | $362K | 6/13/2025 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 6,940 | $506K | 6/13/2025 | View on chart |
| VRSK | ▼ Sell | Open Market | 10,503 | $3.3M | 6/13/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 735 | $0 | 5/20/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 101 | $0 | 3/31/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 109 | $0 | 12/31/2024 | View on chart |
| VRSK | ▼ Sell | Open Market | 3,353 | $889K | 10/4/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 112 | $0 | 9/30/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 92 | $0 | 6/30/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 847 | $0 | 5/15/2024 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 5,686 | $346K | 5/3/2024 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 8,369 | $510K | 5/3/2024 | View on chart |
| VRSK | ▼ Sell | Open Market | 926 | $218K | 5/3/2024 | View on chart |
| VRSK | ▼ Sell | Open Market | 10,016 | $2.4M | 5/3/2024 | View on chart |
| VRSK | ▼ Sell | Open Market | 3,113 | $730K | 5/3/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 84 | $0 | 3/31/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 82 | $0 | 12/31/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 83 | $0 | 9/30/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 42 | $0 | 6/30/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,912 | $298K | 6/6/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 6,677 | $405K | 6/6/2023 | View on chart |
| VRSK | ▼ Sell | Open Market | 11,589 | $2.6M | 6/6/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 958 | $0 | 5/17/2023 | View on chart |
| VRSK | ▼ Sell | Open Market | 587 | $119K | 8/11/2022 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 2,486 | $118K | 8/11/2022 | View on chart |
| VRSK | ▲ Buy | Grant | 449 | $0 | 7/1/2022 | View on chart |
| VRSK | ▲ Buy | Grant | 792 | $0 | 7/1/2022 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 9,675 | $477K | 6/9/2022 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,257 | $210K | 6/9/2022 | View on chart |
| VRSK | ▼ Sell | Open Market | 4,039 | $687K | 6/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Verisk price targets trimmed as analysts weigh AI impact
BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.
Verisk price targets trimmed as analysts weigh AI impact. BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.